Status:
COMPLETED
Automated Prize-based Contingency Management to Increase Counseling Attendance in Opiate-Replacement-Therapy Patients
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Opiate-Replacement Therapy
Eligibility:
All Genders
18-65 years
Phase:
EARLY_PHASE1
Brief Summary
Background: \- Treatment outcomes for substance abuse are improved by regular attendance at counseling sessions, and attending at counseling sessions can be futher improved by prize-based incentives....
Detailed Description
Background. Community implementation is a barrier to technology transfer of contingency management (CM), an effective behavioral treatment for substance dependence. The Biomedical Informatics Section ...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Enrollment in a substance abuse treatment protocol in Archway, with attendance having started at least 4 weeks prior to admission into this protocol (to allow time for stabilization in treatment).
- EXCLUSION CRITERIA:
- Less than 14 weeks remaining in primary protocol.
Exclusion
Key Trial Info
Start Date :
October 3 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 19 2012
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT01229163
Start Date
October 3 2010
End Date
April 19 2012
Last Update
April 5 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute on Drug Abuse, Biomedical Research Center (BRC)
Baltimore, Maryland, United States, 21224